GeraldAlanFaichMDFACP, FACPM. FISPE

PubMed

• 167 citations
  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled ...
  F E Silverstein, G Faich, J L Goldstein, L S Simon, T Pincus
  JAMA. 2000-09-13
• 169 citations
  Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac.
  William B. White, Gerald A. Faich, Andrew Whelton, Clement Maurath, Nancy J Ridge
  The American Journal of Cardiology. 2002-02-15
• 29 citations
  Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database
  Megan E. McAuliffe, Stephan Lanes, Timothy Leach, Asit Parikh, Gerald Faich
  Current Medical Research and Opinion. 2015-07-02

Journal Articles

• Reynolds Lessons Learned in the Conduct of a Global, Large Simple Trial of Treatments Indicated for Schizophrenia  
  Contemp. Clin Trials, 1/1/2013
• PV and Signaling and Disproportionality  
  Faich G, Morris J, Drug Info J, 1/1/2012
• Comment on FDA's Quality Assessment of ADE Reports from an Electronic Health Record Project  
  Faich G, Pharmacoepi and Drug Safety, 1/1/2012
• Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Car...  
  Brian L. Strom, Sybil M. Eng, Gerald Faich, Robert F. Reynolds, Ralph B. D'Agostino, Jeremy Ruskin, and John M. Kane, Am J Psychiatry, 1/1/2011
• The Ziprasidone Observational Study of Cardiac Outcomes (Zodiac): Design and Baseline Subject Characteristics  
  Strom BL, Faich GA, Reynolds RF, Eng SM, D'Agostino RB, Ruskin JN, Kane JM, J Clinic Psychiatry, 1/1/2008
• Cardiac Safety of Diabetes Therapies and Postmarketing Requirements  
  Faich G, Stemhagen A, Pharmacopepi and Drug Safety, 1/1/2008
• Incidence of Allergic Reactions Associated with Antibiotics  
  Johannes CB, Ziyadeh Najat, Seeger J, Tucker E, Reiter C, Faich G, Drug Safety, 1/1/2007
• Points to Consider: The Roles of Surveillance and Epidemiology in Advancing Drug Safety  
  Edwards R, Faich G, Tilson H, Pharmicoepi and Drug Safety, 1/1/2005
• Administration of Parenteral Iron and Mortality among Hemodialysis Patients  
  Feldman HI, Joffe M, Robinson B, Knauss J, Cizman B, Guo W, Franklin-Becker E, Faich G, J Am Soc Nephrol, 6/1/2004
• Clinical Experience with Moxifloxacin in Patients with Respiratory Tract Infections  
  Faich GA, Morganroth J, Whitehouse AB, Brar JS, Arcuri P, Kowalshy SF, Haverstock DC, Celesk, RA, Church DA, Ann Pharmacother, 1/1/2004
• Epidemiologic Vs Post-marketing Spontaneous Report Data: Vive La Difference  
  Holden WL, Scarazzini L, Faich G, Pharmacoepid Drug Safety, 1/1/2004
• Cardiovascular Thrombotic Events in Arthritis Trials of the Cyclooxygenase 2 Inhibitor Celecoxib  
  White W, Faich G, Makuch R, Borer J, Am J Cardiol, 1/1/2003
• Comparison of Thromboembolic Events in Patients Treated with Celecoxib Vs Ibuprofen or Diclofenac  
  White W, Faich G, Whelton A, Maurath C, Ridge N, Verberg K, Geis S, Lefkowith J, Amer J Cardiology, 1/1/2002
• Iron Administration and Clinical Outcomes in Hemodialysis Patients  
  Feldman H, Santanna J ….Faich G, J of Am Society of Nephrology, 1/1/2002
• Troglitazone (Rezulin) And Hepatic Injury  
  Faich GA, Moseley RH, Pharmacoepidemiology and Drug Safety, 1/1/2001
• Blood Pressure Lowering Agents (Letter)  
  Faich GA, Makuch R, Lancet, 1/1/2001
• Gastrointestinal Toxicity with Celecoxib Vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis: The CLASS Study; A Randomized Controlled ...  
  Silverstein FD, Faich G, Goldstein JL, et al, JAMA, 1/1/2000
• Ferrlecit: Safer Intravenous Iron Therapy Than Iron Dextran  
  Faich GA, Strobos J, Am J of Kid Dis, 1/1/1999
• Verapamil Use in Patients with Cardiovascular Disease: An Overview of Randomized Trials  
  Pepine C,Faich GA, Makuch R, Clin Cardiol, 1/1/1998
• Black Box Warnings In Prescription Drug Labeling: Results of a Survey of 206 Drugs  
  Beach JE, Faich GA, Sasinowski F, Food and Drug Law Journal, 1/1/1998
• Effect of Onychomycosis On Quality of Life  
  Drake L, Scher RK, Smith EB, Faich GA, J Am Acad Derm, 1/1/1998
• US Adverse Drug Reaction Surveillance 1989-1994  
  Faich, G.A., Pharmacoepidem and Drug Safety, 1/1/1996
• Pharmacotherapy for Obesity-Do the Benefits Outweigh the Risks?  
  Manson J., Faich G.A., New Eng J Med, 1/1/1996
• Terfenadine - Associated Ventricular Arrhythmias A Retrospective Cohort Comparison Among Members of an HMO  
  Hanrahan, J.P., Chao, P.W., Carlson, W., Greineder, D., Faich, G.A., and Platt, R., Annals of Epidemiology, 1/1/1994
• Phase IIIB and Treatment IND Safety Reporting  
  Faich GA, Drug Info J, 1/1/1993
• Join now to see all

Books/Book Chapters

• Practical Risk Management 
  Chapter: Signaling and Risk Assessment 
  Faich G, Clark JEditors: Federman J, Pines WL, Slatko G.Food and Drug Law Institute2008
• Practical Risk Management 
  Chapter: Evaluation of Risk Management Programs 
  Faich G, Stemhagen AEditors: Fedderman J, Pines WL, Slatko G.Food and Drug Law Institute2008
• Cardiac Safety of Noncardiac Drugs:Practical Guidelines for Clinical Research and Drug Development 
  Chapter: Cardiac Arrhythmia Assessment in Phase IV Clinical Studies 
  Faich G, Stemhagen AEditors: J. Morganroth and I. Gussak.Humana Press Inc., Totowa. NJ2005
• Obesity and Redux 
  Chapter: Fenfluramines, Obesity and Primary Pulmonary Hypertension 
  Page 99 - 104Faich, G.A.1997
• Clinical Trials and Tribulations 
  Chapter: Postmarketing Surveillance for Drug Safety 
  Page 347 - 61Faich, G.A., Guess, H.A., and Kuritsky, J.N.Editors: Cato A.Marcel Dekker, Inc., NY1988
• The USA in Monitoring for Drug Safety 
  Page 153 - 164Jones, J.K., Faich, G.A., and Anello, C.Editors: Inman WHW.MTP Press Ltd., Lancaster, BostonEdition 2nd,1986
• Textbook of Communicable and Infectious Diseases 
  Chapter: Bacterial Food Poisoning 
  Page 259 - 266Faich, G.A. and Gangarosa, E.J.Editors: F. Top.Mosby Co, St. Louis1973
• Join now to see all

Abstracts/Posters

• International Reporting of ADRs, Final Report of the CIOMs Working Group
  Faich, G.A., Castle, W., Bankowski, Z., and the ADR Working Group, CIOMs c/o WHO Geneva 1990, and Drug Information Journal, 1/1/1990

Lectures

• International Reporting of Adverse Drug Reactions, CIOMS Working Group Report, Pamphlet 
  Geneva - 1/1/1987
• Postmarketing Surveillance. Monograph 
  Clinical Medicine Research Institute, NYC - 10/1/1986